Paper Details

  1. Home
  2. Paper Details

Neuropsychiatric side effects of FK506 vs. cyclosporine A. First-week postoperative findings.

Author: DiMartiniA F, FaettD, FungJ, PajerK A, TrzepaczP T

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This study compared the neuropsychiatric side effects of FK506 and cyclosporine A in liver transplant patients. The study found no significant differences between the two drugs, although both were associated with some cognitive impairment. These findings suggest that both drugs are well tolerated in terms of neuropsychiatric side effects.
Paper Details　
Original Abstract of the Article :
The authors studied 31 liver transplant patients to compare neuropsychiatric side effects of a newer immunosuppressant, FK506, to cyclosporine A (CYA). Patients were randomly assigned to either FK506 or CYA. At the 1-week postoperative stage, cognitive status was assessed with the Mini-Mental State ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/S0033-3182(97)71402-6

データ提供：米国国立医学図書館（NLM）

FK506 vs. Cyclosporine A: Navigating the Post-transplant Desert

Liver transplantation, a life-saving procedure that often involves a delicate dance between the immune system and the transplanted organ, relies on immunosuppressants to prevent rejection. This study delves into the world of these drugs, comparing the neuropsychiatric side effects of FK506, a newer immunosuppressant, to cyclosporine A (CYA), a well-established medication. The researchers meticulously evaluated cognitive status in 31 liver transplant patients, using various tests to assess cognitive function like explorers mapping a vast desert landscape. The findings were intriguing: while both drugs demonstrated mild cognitive impairment, FK506 appeared to have a slightly greater impact on certain cognitive functions compared to CYA, suggesting potential differences in their neuropsychiatric profiles.

Cognitive Recovery Post-transplant: A Glimpse of Hope in the Desert

Despite the observed cognitive impairment, the study revealed encouraging signs of recovery at the 1-week postoperative stage. The patients showed a remarkable improvement in their cognitive function, like a parched land slowly recovering from a desert rain.

Navigating the Post-transplant Journey: A Collaborative Approach

This research highlights the importance of carefully monitoring cognitive function in liver transplant patients receiving immunosuppressants. A multidisciplinary approach involving physicians, nurses, and therapists can help to manage potential neuropsychiatric side effects and ensure optimal recovery.

Dr. Camel's Conclusion

This study provides valuable insights into the neuropsychiatric profiles of FK506 and CYA, shedding light on the challenges and opportunities in managing immunosuppressant therapy post-liver transplantation. The researchers' meticulous observations, like grains of sand revealing the intricate patterns of a desert landscape, offer crucial information for optimizing patient care and promoting well-being in the post-transplant journey.

Date :
  1. Date Completed 1998-03-24
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

9427854

DOI: Digital Object Identifier

10.1016/S0033-3182(97)71402-6

Related Literature

Article Analysis
・Side Effects of cyclosporine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.